CASES Insights Into Current Approaches in HER2+ Breast Cancer

Perspectives on current treatment practices focusing on HER2+ breast cancer

November 2, 2020
Purchase Report

Faculty Chair

Ian Krop, MD

Dana-Farber Cancer Institute, Boston, MA, USA

Example Report

Start discovering the insights

View Report

REPORT SNAPSHOT

Insights on the current approaches in HER2+ breast cancer were obtained from

  • Current treatment practices regarding HER2+ metastatic breast cancer (mBC)
  • Management of progressive HER2+ metastatic disease
  • Current treatment practice attitudes toward recently introduced and upcoming agents

GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT

  • A moderated virtual roundtable discussion focusing on treatment of HER2+ breast cancer was held on November 2, 2020
  • The group of advisors comprised 27 community oncologists from the southeast region of the US
  • Data collection was accomplished through use of audience response system questioning both prior to and following the expert’s presentation and discussion with the faculty panel

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.